SOBRsafe Inc. (NASDAQ: SOBR), a provider of next-generation alcohol detection technology, has entered into definitive agreements for the immediate exercise of certain outstanding warrants at a reduced exercise price of $1.05 per share. The transaction is expected to generate gross proceeds of approximately $3.1 million before fees and expenses.
In connection with the warrant exercise, the company will issue new unregistered Series E and Series F warrants to purchase an aggregate of 4.7 million shares. The offering is expected to close on or about July 16, 2026. Net proceeds from the transaction are designated for working capital and general corporate purposes. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering.
The capital raise comes as SOBRsafe continues to advance its transdermal alcohol detection technology, which detects the presence of alcohol as emitted through a user's skin in real time, without requiring breath, blood, or urine samples. The company's platform provides passive, dignified screening and monitoring solutions for behavioral health, family law, consumer markets, and licensing and integration applications.
This financial milestone provides SOBRsafe with additional resources to support its operational initiatives and market expansion. The funds are expected to bolster the company's balance sheet and enable continued investment in technology development and commercial activities. For more details on the transaction, refer to the full press release at https://nnw.fm/jzJjF.
SOBRsafe's technology is designed to enable trust and empower recovery with a human touch. The company's advanced transdermal sensors and powerful backend data platform offer a non-invasive alternative to traditional alcohol monitoring methods. The new warrants provide investors with additional upside potential as the company executes its growth strategy.
The offering is being conducted as a private placement under Section 4(a)(2) of the Securities Act of 1933 and Regulation D promulgated thereunder. The securities issued have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Investors interested in the latest news and updates relating to SOBR can visit the company's newsroom at https://nnw.fm/SOBR. SOBRsafe's innovative approach to alcohol detection positions it as a key player in the behavioral health and safety monitoring markets.
